In the long tradition of medicine's most consequential accidents, researchers at the Medical University of South Carolina discovered while studying kidney disease that formoterol — an asthma drug prescribed for decades — may reverse fatty liver disease by restoring the energy-producing capacity of damaged cells. The finding arrives at a moment when MASH, a progressive liver condition tied to obesity and diabetes, affects hundreds of millions worldwide and remains largely without effective treatment. Human trials are now underway, carrying the quiet possibility that a familiar, inexpensive drug
News-Medical
· May 09, 2026
· health
· 4 min de lectura
Medium
Verificación: Caracterizado
Asthma drug formoterol shows potential to reverse fatty liver disease in mice
MASH affects hundreds of millions worldwide and is a leading cause of liver transplantation and liver failure.
◉
Health & Medicine
8046 artículos relacionados
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 100% coincidencia
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% coincidencia
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% coincidencia
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% coincidencia
Canada faces new COVID epidemic, not third wave, as variants target di…
The Globe and Mail · 99% coincidencia
Cobertura Relacionada
Google News · Aug 19
Welsh Teen's Ovarian Cancer Diagnosis Triggers Sudden Menopause
A teenager from Caernarfon experienced sudden onset menopause following an ovarian cancer diagnosis, highlighting unexpe…
JNS.org · Aug 19 Israeli study: Focused attention may reduce inflammatory responseBar-Ilan University researchers found that deliberately focusing attention on inflamed skin areas reduced inflammatory r…
foodsafetynews.com · Aug 19 UK Salmonella outbreak sickens 207, linked to imported eggsA Salmonella outbreak across the UK has infected 207 people with one death, traced to contaminated imported eggs served …
eNCA · Aug 19 DRC Ebola outbreak spreading faster than any previous epidemic, WHO warnsWHO warns the DRC Ebola outbreak is moving faster than any previous epidemic, with over 2,300 deaths from nearly 5,000 c…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Medical research discovery of asthma drug's potential liver disease treatment has no direct geopolitical implications; primarily a scientific/pharmaceutical development.
Escalation Risk
low
Confidence
HIGH
No immediate power dynamics shifts. Potential long-term pharmaceutical market competition if formoterol proves effective in human trials for MASH treatment.
Lente Económico
📈
Asthma drug formoterol shows potential to treat fatty liver disease (MASH) by improving mitochondrial function, with human trials underway, potentially creating a new therapeutic market and repurposing opportunity.
Market Signal
bullish
Confidence
MED
Pharmaceutical/Biotechnology
Healthcare/Medical Devices
Respiratory Medicine
Hepatology/Liver Disease Treatment
Clinical Research and Development
If confirmed in human trials, patients with MASH could access an affordable, existing medication rather than waiting for new treatments, reducing healthcare costs and improving outcomes for hundreds of millions affected by fatty liver disease globally.
FDA may expedite approval pathways for drug repurposing; healthcare systems may expand formoterol prescribing beyond respiratory conditions; insurance coverage policies may evolve to include hepatic indications; regulatory frameworks for off-label use may be clarified.